ResEcon Blog Key Takeaways from 25th Annual Pharma Congress

General Counsel, outside counsel, compliance executives, representatives of regulatory bodies and forensic practitioners met and discussed an array of issues at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress. The following highlights a few key topics.   Artificial Intelligence (AI) in the Life Sciences Industry Robust AI governance is essential, requiring multidisciplinary… The post Key Takeaways from 25th Annual Pharma Congress appeared first on ResEcon.